FACULTY

S U M M I T C O - C H A I R S

Meet the key LEADERS behind the SAN SEBASTIAN INTERNATIONAL GENITOURINARY CANCER SUMMIT 2026.

Andrea B. Apolo, M.D., is an internationally recognized expert in bladder cancer research. She was recruited to the National Cancer Institute’s (NCI’s) Physician-Scientist Early Investigator Program in 2010 to build a translational bladder cancer program. In 2014 she received the Lasker Clinical Research Scholars Award and in 2021 was awarded tenure at the National Institutes of Health (NIH). Dr. Apolo serves within the NCI’s Center for Cancer Research (CCR) as Head of the Genitourinary Malignancies Branch’s Bladder Cancer Section and Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic.

Medical Oncology Department Director at Quironsalud Madrid, Spain. Dr. Enrique Grande, MD, PhD, Msc, research is focused on genitourinary and endocrine tumors and actively contributes to the development of the Translational Research and Early Drug Development Unit. Dr. Grande was awarded his PhD for a pharmacokinetic and pharmacodynamic study of tyrosine kinase inhibitors in liver metabolism, and he holds a master’s degree in molecular biology of cancer from the Spanish National Cancer Research Centre (CNIO). Published author of more than 200 manuscripts in peer-reviewed journals, Dr. Grande is also the founder of the Spanish Group of Research on Orphan and Uncommon Tumors (GETHI).